New ProBeam 360 Degree Proton Therapy System Allows Adaptive Precision Radiation Therapy
The ProBeam® 360 Degree Proton Therapy System is offered with iterative cone-beam CT imaging and high-definition pencil-beam scanning technology. The system comes with 360-degree rotating gantry that allows efficient Intensity Modulated Proton Therapy. The embedded RapidScan™ technology simplifies the process of motion management. The rotating gantry increases treatment times by the reducing patient repositioning and re-imaging.This story is related to the following:Electrotherapy Equipment (Source: Industrial Newsroom - Health, Medical and Dental Supplies)
Source: Industrial Newsroom - Health, Medical and Dental Supplies - October 23, 2018 Category: Medical Devices Source Type: news

Mevion constructs 2nd proton system in St. Louis
Mevion Medical Systems said it's constructing a second proton therapy system...Read more on AuntMinnie.comRelated Reading: Mevion secures $150M in financing Mevion treats 1st patient with proton therapy system Mevion nabs FDA OK for proton therapy system Mevion submits 510(k) to FDA for proton therapy system Mevion touts scanning milestone (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 22, 2018 Category: Radiology Source Type: news

Cincinnati Children ’s, UC Health research 1-second cancer treatment
The Proton Therapy Center operated by Cincinnati Children ’s Hospital and UC Health is one of the founding members of the FlashForward Consortium, an international group researching the use of high doses of proton beams delivered at ultra-high speeds to treat cancer. The so-called flash therapy, which is delivered in one to three sessions that each last less than one second, represents a promising new direction in the treatment of cancer. The 13-member consortium intends to expand on preclinical… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - October 22, 2018 Category: Health Management Authors: Barrett J. Brunsman Source Type: news

Cincinnati Children ’s, UC Health research 1-second cancer treatment
The Proton Therapy Center operated by Cincinnati Children ’s Hospital and UC Health is one of the founding members of the FlashForward Consortium, an international group researching the use of high doses of proton beams delivered at ultra-high speeds to treat cancer. The so-called flash therapy, which is delivered in one to three sessions that each last less than one second, represents a promising new direction in the treatment of cancer. The 13-member consortium intends to expand on preclinical… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 22, 2018 Category: Biotechnology Authors: Barrett J. Brunsman Source Type: news

Maryland Proton Treatment Center offers thermal therapy in combination with proton therapy
(University of Maryland Medical Center) The Maryland Proton Treatment Center (MPTC) is now offering deep-tissue external thermal therapy in combination with high-precision proton-beam radiotherapy as a potential way to boost survival chances for certain cancer patients. MPTC is the only center in the world to offer these two treatments at the same facility, an advantage to patients because these therapies are typically given within an hour of each other. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 8, 2018 Category: Cancer & Oncology Source Type: news

International Symposium on Mesothelioma to Focus on Immunotherapy
The eighth annual International Symposium on Malignant Pleural Mesothelioma Saturday at UCLA will reflect the rapidly evolving philosophy on future treatment of this rare cancer. Change is coming. The Symposium, which was first held in 2011 to help bring awareness to lung-sparing surgery, will highlight groundbreaking discoveries and the latest advances in immunotherapy and gene therapy — believed to be the future of cancer care. The longtime chemotherapy and surgery standard-of-care routine is fading. The symposium at the Luskin Conference Center on the UCLA campus in Los Angeles will help explain why. “There is so mu...
Source: Asbestos and Mesothelioma News - September 26, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

IBA receives Brazil's OK for proton therapy system
Proton therapy developer Ion Beam Applications (IBA) has received clearance...Read more on AuntMinnie.comRelated Reading: IBA wins Singapore contract Purchase delays affect IBA's 6-month results IBA lands Ariz. installation IBA posts mixed 2017 results IBA posts revenue decreases in Q3 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 19, 2018 Category: Radiology Source Type: news

Hitachi's First Dedicated Compact Proton Therapy System to be Supplied to Tokushukai Medical Group
System will be Installed at Shonan Kamakura Advanced Medical Center, Scheduled to be Complete in September 2020 TOKYO, Sept 14, 2018 - (JCN Newswire) - Hitachi, Ltd. (TSE: 6501) announced today that it has received an order for the compact proton therapy system from Tokushukai Medical Group, and the system will be installed at Shonan Kamakura Advanced Medical Center, which is planned to be built near Shonan Kamakura General Hospital. This is the first order for...This story is related to the following:Radiotherapy Systems (Source: Industrial Newsroom - Health, Medical and Dental Supplies)
Source: Industrial Newsroom - Health, Medical and Dental Supplies - September 17, 2018 Category: Medical Devices Source Type: news

Dr. Jeff Balser Named to Varian Board of Directors
PALO ALTO, Calif., Sept. 12, 2018 -- (Healthcare Sales & Marketing Network) -- Varian (NYSE : VAR ) today announced that Jeffrey R. Balser, MD, PhD, president and chief executive officer at Vanderbilt University Medical Center and dean of Vanderbilt Unive... Devices, Oncology, Personnel Varian Medical Systems, ProBeam, proton therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 12, 2018 Category: Pharmaceuticals Source Type: news

Varian Installs Cyclotron for ProBeam Compact Proton Therapy System at Treatment Center in Florida
PALO ALTO, Calif., Sept. 4, 2018 -- (Healthcare Sales & Marketing Network) -- Varian (NYSE : VAR ) today announced the installation of the cyclotron for the Varian ProBeam® Compact single-room proton therapy system at the cancer treatment center on th... Devices, Oncology Varian Medical Systems, ProBeam, proton therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 4, 2018 Category: Pharmaceuticals Source Type: news

Success of proton therapy may depend on who pays for it
The financial success of a proton therapy facility may depend on who pays for...Read more on AuntMinnie.comRelated Reading: Insurers reverse 97% of pediatric proton denials on appeal U.S. proton therapy market to reach $1B by 2022 Simple procedures are keys to success of proton facilities (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 30, 2018 Category: Radiology Source Type: news

Purchase delays affect IBA's 6-month results
Proton therapy developer Ion Beam Applications (IBA) is blaming "low revenue...Read more on AuntMinnie.comRelated Reading: IBA lands Ariz. installation IBA posts mixed 2017 results IBA posts revenue decreases in Q3 IBA, Elekta join forces on software development IBA posts half-year revenue increases (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 23, 2018 Category: Radiology Source Type: news

Proton Therapy Trials'at Risk,' Slow to Enroll Patients Proton Therapy Trials'at Risk,' Slow to Enroll Patients
Is proton therapy better than standard radiotherapy in the treatment of cancer? Seven major randomized clinical trials have no answers at this point.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 12, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Why randomized trials for proton therapy are difficult to complete (and what we can do about it)
(University of Pennsylvania School of Medicine) Commercial insurance medical policies that do not cover treatment with proton therapy can make it difficult for patients to participate in randomized clinical trials funded by the NCI, part of the National Institutes of Health, that are evaluating the therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 11, 2018 Category: International Medicine & Public Health Source Type: news

I'm first person to have proton therapy in the UK
THE first indication there was something wrong came last summer when Simon Hardacre began to feel stressed and run down. Like many men he was inclined to attribute his condition to the wear and tear of life but after encouragement from partner Maria Kose, 40, he went to see a GP. (Source: Daily Express - Health)
Source: Daily Express - Health - July 11, 2018 Category: Consumer Health News Source Type: news